dronabinol has been researched along with Mood Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Felice, M; Hudson, R; Laviolette, SR; Pereira, BJ; Renard, J; Rushlow, WJ; Schmid, S; Szkudlarek, HJ | 1 |
| Kohnz, RA; Nomura, DK | 1 |
| Ashton, CH; Moore, PB | 1 |
| Koethe, D; Leweke, FM | 1 |
| Ricklin, F | 1 |
4 review(s) available for dronabinol and Mood Disorders
| Article | Year |
|---|---|
Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids.
Topics: Animals; Arachidonic Acids; Dronabinol; Eicosanoids; Endocannabinoids; Enzyme Inhibitors; Glycerides; Humans; Lipoprotein Lipase; Monoacylglycerol Lipases; Mood Disorders; Neoplasms; Neurodegenerative Diseases; Pain; Signal Transduction | 2014 |
Endocannabinoid system dysfunction in mood and related disorders.
Topics: Anxiety; Bipolar Disorder; Cannabidiol; Cannabinoid Receptor Modulators; Cannabinoids; Cerebral Cortex; Depression; Dronabinol; Electroencephalography; Endocannabinoids; Humans; Mood Disorders; Pain; Receptors, Cannabinoid; Schizophrenia; Suicide | 2011 |
Cannabis and psychiatric disorders: it is not only addiction.
Topics: Affect; Animals; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Cognition Disorders; Depressive Disorder, Major; Dronabinol; Drug Interactions; Humans; Marijuana Abuse; Mood Disorders; Psychoses, Substance-Induced; Receptor, Cannabinoid, CB1; Risk Factors; Schizophrenia; Signal Transduction | 2008 |
[Cannabis: a harmless drug?].
Topics: Animals; Central Nervous System; Dronabinol; Gonads; Humans; Immune System; Male; Marijuana Abuse; Mitosis; Mood Disorders; Respiratory System; Spermatozoa; Substance-Related Disorders | 1989 |
1 other study(ies) available for dronabinol and Mood Disorders
| Article | Year |
|---|---|
l-Theanine Prevents Long-Term Affective and Cognitive Side Effects of Adolescent Δ-9-Tetrahydrocannabinol Exposure and Blocks Associated Molecular and Neuronal Abnormalities in the Mesocorticolimbic Circuitry.
Topics: Animals; Anxiety; Cerebral Cortex; Cognition Disorders; Dronabinol; Glutamates; Glycogen Synthase Kinase 3; Hallucinogens; Male; Mood Disorders; Nerve Net; Neurons; Neuroprotective Agents; Oncogene Protein v-akt; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Social Behavior; Ventral Tegmental Area | 2021 |